CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Operating expenses:
Research and development	$ 1,599,550	$ 989,092
General and administrative	1,597,936	1,427,793
Total operating expenses	3,197,486	2,416,885
Loss from operations	(3,197,486)	(2,416,885)
Other income (expense):
Change in fair value of warrant liabilities	1,000	(3,000)
Net loss	$ (3,196,486)	$ (2,419,885)
Net loss per share, Basic and Diluted	$ (0.30)	$ (0.29)
Weighted average number of common shares outstanding	10,622,420	8,429,595